SECsense Logo

Cara Therapeutics, Inc. 8-K/A Filing: Key Financial Insights & Updates

$CARA
Form 8-K/A
Filed on: 2024-12-20
Source
Cara Therapeutics, Inc. 8-K/A Filing: Key Financial Insights & Updates

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Cara Therapeutics, Inc.
  • CIK (Central Index Key): 0001346830
  • SEC File Number: 001-36279
  • Tax ID: 75-3175693
  • Address: 400 Atlantic Street, Suite 500, Stamford, CT 06901
  • Contact Number: 203-406-3700
  1. Filing Details:
  • Filing Type: 8-K/A (amendment to the 8-K filing)
  • Filing Date: December 17, 2024
  1. Financial Reporting Context:
  • Reporting Date: The financial data pertains to December 17, 2024.
  • Currency: The report is denominated in U.S. Dollars (USD).
  • Shares: The report includes metrics related to shares of common stock.
  1. Common Stock Details:
  • Type: Common Stock
  • Par Value: $0.001 per share
  • Trading Symbol: CARA
  • Exchange: NASDAQ

Insights:

  • The filing indicates that Cara Therapeutics is actively reporting to the SEC, which is essential for transparency and compliance with regulatory standards.
  • The inclusion of an 8-K/A suggests there may have been significant events or updates requiring amendments to previous filings, warranting investor attention.
  • The common stock information may be pertinent for investors or analysts assessing the company’s equity valuation and market presence.
  • The address and contact information provided can be useful for direct communications or inquiries regarding the filing or company performance.

This information serves as a snapshot of Cara Therapeutics' current regulatory status and basic corporate metrics as of the specified date.